< Back to companies
Spanios

Spanios

Houston, Texas, United States

Spanios Labs transforms precision oncology research by harnessing Patient-Derived Organoids (PDOs) and Tumoroids (PDTs) to accelerate drug development for rare cancers. Their COMPASS platform utilizes patient-specific 3D tumor models with intact tumor microenvironments (TME) to enable reproducible preclinical studies. By supporting any drug modality against solid cancer indications, Spanios helps scientists fast-track the search for novel cures. Serving drug developers and clinical oncologists, their efficacy-first model removes guesswork from therapeutic validation, aiming to bring hope to millions of patients through faster identification of effective treatments.

Share
Shareable draft
Get Involved in Spanios

Company Info

Founded
2017
Website
www.spanioslab.com/

Categories

Precision MedicineCancerDrug DevelopmentRare Diseases

Disease Areas

Technologies

Organoids & Organ-on-ChipDrug Development3D VisualizationPlatform
Only accessible to MedStartr community members. Join now

What do you think of Spanios?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Spanios
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free